In the opening session on AI and multi-omics for cancer screening and diagnostics, Dr. Le Son Tran, Principal Investigator at ...

AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing non-respiratory symptoms, including dermatologic and neurologic manifestations.

The panel is able to independently predict metastasis, local recurrence, and overall survival in patients with cutaneous squamous cell carcinoma, researchers reported.

The resulting 124 I-evuzamitide (previously known as AT-01) has been shown to detect amyloidosis in organs like the heart, liver, and kidney. Previous work also showed that this amyloid-specific PET ...

WASHINGTON -- Assessing sustained virological response (SVR) to hepatitis C virus (HCV) therapy at 4 weeks after treatment ...

The startup incubator MedTech Innovator only launched in 2013, but it has had an immense impact on the industry. | Three MedTech Innovator startups showed off their diagnostic tech at the American ...

“The 4AT screening tool is a rapid screening tool for the diagnosis of delirium and cognitive impairment. It has a sensitivity and specificity of 88%; it can be done in less than 2 minutes, and it ...

Proteomics helped uncover molecular signatures of multiple sclerosis up to seven years before symptom onset, paving the way ...

Q3 2025 Earnings Call Transcript November 10, 2025 Wave Life Sciences Ltd. misses on earnings expectations. Reported EPS is $ ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Clinical Data—SIMPLIFY Study -- Updated analysis increased Gallery's PPV in symptomatic patients to 84.2% after long-term ...